Suprefort®
CONCLUSION
Biologically active food supplement SUPREFORT® has a normalizing effect on the functional activity
of pancreatic cells.
SUPREFORT® is well tolerated when administered orally, has no side effects, and can be used as a ther-
apeutic and prophylactic biologically active food supplement in the complex treatment of pancreatic
dysfunction.
- To patients with chronic pancreatitis - orally 10-15 minutes before meals, 1-2 tablets or capsules 2
times a day for 15 days;
- To patients with diabetes mellitus - orally 10-15 minutes before meals, 1 tablet or capsule 2 times a
day for 15 days under the control of blood glucose.
It is advisable to repeat the course of treatment in 3-6 months
REFERENCES
1. Balabolkin M.I. Diabetes Mellitus / Endocrine Diseases / / Diagnosis and Treatment of Internal Dis-
eases: A Guide for Physicians. Ed. F.I. Komarova. - M.: Medicine, 1991. - T. 2. - S. 465-492.
2. Belousov Y.B., Moiseev V.S., Lepakhin V.K. Clinical Pharmacology and Pharmacotherapy: A Guide for
Physicians. - M.: the Universe, 1993. -- 398 p.
3. Internal Diseases / Ed. A.S. Smetnev, V.G. Kukes. - M.: Medicine, 1982. -- 496 p.
4. Yordanov D., Nikolov P., Boychinov Asp. Phytotherapy. - Sofia: Medicine and Physical Education,
1972. -- 346 p.
5. Mashkovsky M.D., Medicines: Pharmacotherapy for doctors, manual: 2 parts. – Vilnius: ZAO “Gam-
ta”, 1993.
6. Geriatric manual / Ed. D.F. Chebotarev, N.B. Mankovsky. – M.: Medicine, 1982. – 544 p.
7. Tepperman J., Tepperman H. Physiology of metabolism and the endocrine system: Translation from
English - M. Mir, 1989. -- 656 p.
RECOMMENDATIONS FOR USE
A complex of peptides isolated from the pancreas. The isolated peptides have a selective effect on var-
ious cells of the pancreas, normalize metabolism in cells, and regulate the functions of the pancreas.
In a clinical study, the effectiveness of SUPREFORT® was established for the complex restoration of
pancreatic functions after past pancreatic diseases of various origins, in pathological conditions leading
to pancreatic dysfunction, exposure to extreme environmental factors, impaired carbohydrate metabo-
lism, malnutrition, and also during aging.
Responsible executor: A.A. Veretenko Executor: O.U. Raigorodsky
Deputy Director of the LLC «Medical Center Chief Physician of the LLC «Medical Center of
of the St. Petersburg Institute of Bioregulation the St. Petersburg Institute of Bioregulation
and Gerontology, SZO RAMS» for clinical work, and Gerontology, SZO RAMS», Candidate of
Candidate of Medical Sciences (PhD in Medical Medical Sciences (PhD in Medical Science)
Science), Associate Professor
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.